Periodontal Disease Therapeutics Market Opportunity Analysis 2018 - 2026

Periodontal Disease Therapeutics
Market - Size, Share, Outlook, and
Opportunity Analysis, 2018 - 2026
Periodontal Disease Therapeutics Market by Drug Type (Arestin,
Atridox, Doxycycline, Metronidazole, Minocycline, Periochip, and
Others), by Distribution Channel (Hospital Pharmacies, Retail
Pharmacies, and Online) - Size, Share, Outlooks, and Opportunity
Analysis 2018 - 2026
Periodontitis is a chronic bacterial infection caused by microbial plaque often known as gum
disease that is colonized on tooth surface and below the gingival margin. It involves progressive
loss of the alveolar bone, which is a thickened ridge of bone that contains tooth socket over the
bones that holds teeth. According to National Institutes of Health 2017, around 20-15% of global
population is estimated to suffer from severe periodontitis in comparison to 5-10% in 2004,
which is propelling demand for its diagnosis and treatment worldwide in the medical industry.
In periodontitis, gums are pulled away from teeth and form spaces (pockets), which are prone to
get infected. If such infection is untreated, it can lead to increase periodontal pocket length and
bleeding on probe, in turn leading to the alveolar bone loss and teeth loss. In order to
complement a non-surgical therapy in periodontitis multiple antimicrobial options are available,
such as metronidazole, chlorhexidine, minocycline, doxycycline, tetracycline, which can be
locally delivered to mucosa. These drugs are used to inhibit periodontopathogenic microorganism
as well as modulate the inflammatory response of tissues. Oral care and dental hygiene are one
of the major concerns worldwide. High prevalence of periodontal disease is propelling demand
for oral treatment. Periodontal disease is a result of various risk factors, such as aging, smoking,
poor oral hygiene, heredity, stress, and other medical conditions.
Request Sample Copy of this Business Report @
https://www.coherentmarketinsights.com/insight/request-sample/2022
Periodontal disease are majorly observed in adults. According to the Centre for Disease Control
and Prevention (CDC), in 2018, the prevalence of periodontitis has been estimated to be over
50% in U.S. adults aged 30 years and older i.e. 64.7 million Americans. Among those adults,
8.7% showed mild disease, 30% demonstrated moderate disease, 8.5% had severe chronic

periodontitis. Disease prevalence increases with age, with 70% adults, who are 65 years and
above, suffering from periodontitis. There are many environmental risk factors that are
associated with inflammatory responses, which include smoking, diabetes mellitus, and poor
health habits driving the chronic inflammatory response in periodontitis, and are beneficial for
the periodontitis disease therapeutic market.
Local antibiotics for the treatment of periodontal disease to present more growth opportunities in
the periodontal disease therapeutics market. Increasing preference for controlled local drug
delivery approaches over systemic drug delivery due to better therapeutic outcomes by
achieving factors such as site specific delivery, low dose requirement, reduces side effects favors
the growth of local antibiotics. Furthermore, it provide safe and effective mode of treatment and
is expected to lead the market in the next few years due to various advantages. Systemic
antibiotics is expected to hold dominance in global market due to factors such as product
affordability, availability, and high market penetration. Growing number of preventive care for
dental and gum problems and poor reimbursement policies in many economies are hindering the
growth of periodontal disease therapeutic market.
Based on geography, North America dominated the periodontal disease therapeutics market due
to high awareness of periodontal disease. High prevalence of periodontal disease due to desk
bound or seated lifestyle, efficient reimbursements, and drug abuse. Also, increased healthcare
spending has contributed to growth of market. For instance, in the U.S., according to the Centers
for Medicare and Medicaid Services (CMS) spending for dental services increased by 4.6% in
2016, to US $124.4 Bn, a slight acceleration from 4.4% in growth in 2015. Furthermore, Asia
Pacific is expected as an emerging lucrative market for periodontal therapeutics market due to
large patient pool, growing healthcare infrastructure, and expenditure. Also, investments into
research and development for more effective therapies by prominent players in the region drives
the periodontal disease therapeutics market.
Browse More About the Keyword Market Study @
https://www.coherentmarketinsights.com/ongoing-insight/periodontal-disease-therapeuticsmarket-2022
Report includes chapters which deeply display the following deliverable about industry:
• Periodontal Disease Therapeutics Market Research Objective and Assumption
• Periodontal Disease Therapeutics Market Purview - Report Description, Executive Summary, and
Coherent Opportunity Map (COM)
• Periodontal Disease Therapeutics Market Dynamics, Regulations, and Trends Analysis - Market
Dynamics, Regulatory Scenario, Industry Trend, Merger and Acquisitions, New system
Launch/Approvals, Value Chain Analysis, Porter’s Analysis, and PEST Analysis
• Global Periodontal Disease Therapeutics Market, By Regions
• Periodontal Disease Therapeutics Market Competition by Manufacturers including Production,
Share, Revenue, Average Price, Manufacturing Base Distribution, Sales Area and Product Type.
• Periodontal Disease Therapeutics Market Manufacturers Profiles/Analysis including Company Basic

Information, Manufacturing Base and Its Competitors.
• Periodontal Disease Therapeutics Market Manufacturing Cost Analysis including Key Raw Materials
and Key Suppliers of Raw Materials.
• Industrial Chain, Sourcing Strategy and Downstream Buyers including Upstream Raw Materials
Sourcing and Downstream Buyers
• Marketing Strategy Analysis, Distributors/Traders including Marketing Channel, Market Positioning
and Distributors/Traders List.
• Market Effect Factors Analysis including Technology Progress/Risk, Consumer Needs/Customer
Preference Change and Economic/Political Environmental Change.
• Periodontal Disease Therapeutics Market Forecast including Production, Consumption, Import and
Export Forecast by Type, Applications and Region.
• Research Findings and Conclusion
Table of Contents of Keyword Market Report:
1. Research Objective and assumption
2. Market Purview
3. Market Dynamics, Regulations, and Trends Analysis
4. Keyword Market, By Advanced Water Meters, 2017 - 2025 (USD Million)
5. Keyword Market, By Service, 2017 - 2025 (USD Million)
6. Keyword Market, By Solution, 2017 - 2025 (USD Million)
7. Keyword Market, By Regions, 2017 - 2025 (USD Million)
8. Competitive Landscape
Ask for Discount before Buying @
https://www.coherentmarketinsights.com/insight/request-discount/2022
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready
syndicated research reports, custom market analysis, consulting services, and competitive analysis
through various recommendations related to emerging market trends, technologies, and potential
absolute dollar opportunity.
Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com